| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Data released by the U.S. Department of Health and Human Services shows massive boosts in the use of telehealth during the COVID-19 pandemic. Our digital health company, Pack Health, also saw a surge in the use of our telehealth options over the last two years, including one-to-one health coaching.
The US Department of Health and Human Services announced on Wednesday that it has authorized the Food and Drug Administration to issue emergency use authorizations for monkeypox tests. The agency has issued the first EUA for a monkeypox test to Quest Diagnostics, the FDA said in a separate announcement.
Quest Diagnostics announced August 17th the launch of a new obstetrics laboratory test panel which will help physicians screen all eligible pregnant people easily and reliably for hepatitis C (HCV) along with tests typically ordered during early pregnancy.
Prior to the COVID-19 pandemic, we at Quest Diagnostics had begun the process of moving lab operations in our Northeast region to a new, state-of-the-art facility in Clifton, New Jersey. In January 2021, we started processing samples (both COVID-19 related and others) in the new facility — one of the largest medical laboratories globally.
Responding is Barry Sample, senior science consultant, Quest Diagnostics, Seneca, SC.
Delta-9 THC – the psychoactive compound that gives marijuana users a high – is a real risk to workplace safety and isn’t the benign, harmless substance it may be believed to be by many Americans.